Subject
Clinical Neurology,Neurology,General Medicine
Reference11 articles.
1. Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorder;Biotti;Mult. Scler.,2018
2. Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis;Cohen;Neurology,2019
3. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial;Cree;Lancet,2019
4. Drug-Induced neutropenia: a focus on rituximab-induced late-onset neutropenia;Moore;P T,2016
5. Ocrevus full prescribing information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf. Accessed July 3, 2018.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献